AGF MANAGEMENT LTD

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1003518 TORONTO, A6

Position in REGN

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$320,645

-$3,540 QoQ

Shares Held

415

-1.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AGF MANAGEMENT LTD holds $202,046,769 across 8 Biotechnology names. REGN ranks #8 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	125,069	$91,331,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	201,403	$89,934,495
3	INSM	INSMED Inc	57,458	$9,395,532
4	RPRX	Royalty Pharma plc	81,471	$3,908,163
5	INCY	Incyte Corp	36,452	$3,430,861
6	HALO	Halozyme Therapeutics, Inc.	51,831	$3,349,836
7	ZYME	Zymeworks Inc.	15,000	$375,600
8	REGN	Regeneron Pharmaceuticals, Inc. This page	415	$320,645

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$320,645	415	-1.2%	Shares	Sole	2026-05-07
2025-12-31	$324,185	420	-2.3%	Shares	Sole	2026-02-17
2025-09-30	$241,776	430	-3.4%	Shares	Sole	2025-11-04
2025-06-30	$233,625	445	-64.2%	Shares	Sole	2025-08-06
2025-03-31	$788,347	1,243	-2.7%	Shares	Sole	2025-05-12
2024-12-31	$909,645	1,277	+281.2%	Shares	Sole	2025-02-07
2024-09-30	$352,165	335	-1.8%	Shares	Sole	2024-11-12
2024-06-30	$358,401	341	-70.5%	Shares	Sole	2024-08-07
2024-03-31	$1,112,638	1,156	+58.8%	Shares	Sole	2024-05-13
2023-12-31	$639,395	728	+66.6%	Shares	Sole	2024-02-06
2022-12-31	$315,291	437	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.